QFINITY updates - publications and committee work
QFINITY · Updates

The latest from QFINITY and the field.

An overview of updates beyond events and projects: articles and publications, work in industry bodies and committees, awards, and our perspective on new regulations.

At a glance

Publications, committee work and more.

Titelbild zum Beitrag: ACDM KI Symposium Bericht

At the two-day ACDM AI symposium 2025 in Frankfurt, QFINITY – through COO Marcus Schwabedissen, a standing steering-committee member – again contributed expertise on the validation, compliance, and ethics of AI-enabled systems and led the corresponding track.

In his opening remarks, Ashley Howard reflects on the first ACDM AI Symposium held in London. The photo features, among others, Oliver Herrmann (CEO, QFINITY) taking part in the major panel discussion of 2022.

Following the success of the ACDM AI Conferences over the past three years and the rapid pace of development in Artificial Intelligence, ACDM once again hosted a two-day AI Conference in June 2025.

Responsible AI in clinical trials means being integrated into data-critical processes in a way that is regulatory-robust and ethically sound.

The AI Conference offered a diverse program including innovative training sessions, hands-on case studies, engaging presentations, expert panels, and numerous networking opportunities. The aim was to further the responsible use of AI technologies in clinical trials. Representatives from pharmaceutical companies, CROs, and technology providers gathered in Frankfurt to discuss current developments and future directions in Artificial Intelligence.

QFINITY once again supported the event through Marcus Schwabedissen, COO and a permanent Steering Committee member since 2022, who helped plan, prepare, and run it. He chaired the track on validation, compliance, and ethics in AI.

Given the positive feedback, ACDM looks forward to more successful AI Symposia in the future.

For more information about ACDM events, please click here.

Steering Committee am Konferenztisch, goldene Lichtlinie als entstehendes Programm - 4. ACDM KI Symposium

We are very pleased that QFINITY Qualitätsmanagement was represented on the Steering Committee of the 4th Annual Symposium on Artificial Intelligence in Clinical Trials hosted by the ACDM (Association for Clinical Data Management).

Our colleague Marcus Schwabedissen helped shape the program for this major industry event, together with five fellow experts from leading companies:

– Ashley Howard, Pfizer
– Tim Armitage, Medidata Solutions
– Marcus Schwabedissen, QFINITY Qualitätsmanagement
– Rob Nichols, Coronado Research
– Richard Davies, CluePoints
– Robert King, Thermo Fisher Scientific

The Steering Committee curated a strong, forward-looking program with great dedication and expertise, bringing together leading minds from industry, research, and technology to discuss the current state and future of artificial intelligence in clinical trials.

We thank the ACDM for its trust and for the opportunity to play an active part in shaping the symposium – and we look forward to more initiatives around AI and clinical data management.

Titelbild zum Beitrag: QFINITY bei der SAP & Partners Expert Serie

On May 27, Oliver Herrmann, Managing Director of QFINITY, spoke at the third session of the SAP & Partners Expert Series for Life Sciences. The event focused on one of the key challenges in regulated GxP environments: how to drive innovation without losing sight of compliance.

His presentation centered on one theme: Innovation through modern quality assurance.

In his talk, Mr. Herrmann shared practical approaches that help life sciences companies leverage innovative technologies while still meeting strict regulatory requirements.

Key topics included:

  • The role of Computer Software Assurance (CSA) in fostering critical thinking and modern quality approaches

  • Iterative and incremental methods for meeting compliance requirements

  • Hands-on insights into dealing with CSV requirements and cloud-based solutions

This session was part of a ten-part series specifically designed for companies in life sciences, pharmaceuticals, and medical technology.

You can watch the session recording here:
https://lnkd.in/evupNNxG

Explore the full Expert Series and register here:
https://lnkd.in/evupNNxG

We’re proud to have been part of the SAP & Partners Expert Series.